The Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report by The Business Research Company covers lateral flow immunoassay (LFIA) based rapid test market drivers and restraints, lateral flow immunoassay (LFIA) based rapid test market size, major players, and the impact of COVID-19 on the lateral flow immunoassay (LFIA) based rapid test market.

The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run lateral flow immunoassays (LFIA) based rapid test and related services by companies that develop LFIA based rapid test equipment. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples obtained from the human body or animals, or pollutants in water sources, food or animal feed.

The demand for point-of-care testing under home care settings is expected to drive the LFIA based rapid test market.

The global lateral flow immunoassay (LFIA) based rapid test market is expected to grow from $5.768 billion in 2020 to $6.136 billion in 2021 at a compound annual growth rate (CAGR) of 6.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The LFIA market is expected to reach $9.136 billion in 2025 at a CAGR of 10%.

Request A Sample For The Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp

Some lateral flow immunoassay based rapid test market trends include strategic collaborations. Companies are collaborating to launch new products. In May 2020, Lateral Flow Diagnostic Company Mologic Ltd., which has teamed up with Biosure Ltd., the developer of the only CE approved HIV home testing kit, to develop a COVID-19 antibody self-test. The companies combine Mologic’s validated IgG lateral flow test strip with Biosure’s test kit. In July 2020, MP Biomedicals Asia Pacific Pte Ltd collaborated with a Singapore company A*STAR to create the ASSURE® SARS-CoV-2 IgG / IgM rapid antibody test kit to detect IgG and IgM antibodies in a person infected with SARS-CoV-2. The kit delivers precise results in very less time as less as 15 minutes and uses the lateral flow method.

Global lateral flow immunoassay based rapid test market segments include:

1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay.

2) By End User: Hospital & Clinic, Diagnostic Laboratory, Home Care, Others.

3) By Application: Infectious Disease, Pregnancy & Fertility, Toxicology, Others.

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID 19 Growth And Change to 2030 At:
https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-LFIA-based-rapid-test-global-market-report-2020-30-covid-19-growth-and-change

The Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID 19 Growth And Change to 2030 is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market overviews, analyzes and forecasts market size, share, lateral flow immunoassay (LFIA) based rapid test market players, lateral flow immunoassay (LFIA) based rapid test market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The lateral flow immunoassay (LFIA) based rapid test market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More:

Read Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.

Market Players Covered: Abbott Laboratories, F. Hoffmann-La Roche, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN NV, Hologic Inc., PerkinElmer, Inc., Quidel Corporation.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Here is a list of reports from The Business Research Company similar to the Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021:

Pulse Oximeters And Spirometers Market – By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip, Others), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD, Other General & Surgical Practice, Other Respiratory Diseases), By End-Use (Hospitals, Clinical Laboratories, Home Care), Market Size, Opportunities And Strategies – Global Forecast To 2030

Wearable Blood Pressure Monitors Market – By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies – Global Forecast To 2030

Airway Management Devices Global Market Report 2021: COVID-19 Implications And Growth To 2030